XTANT MEDICAL HOLDINGS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $875.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $875.00K, a 14.23% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $746.00K, a 1.58% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $641.00K, a 43.72% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $766.00K, a 37.62% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $2.89M, a 29.75% decline from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $4.12M, a 50.31% increase from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $2.74M, a 11.16% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $2.46M, a 11.54% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $875.00K 10-Q · filed 2026-08-11 | $1.62M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $746.00K 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $2.89M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $641.00K 10-Q · filed 2025-11-10 | $1.41M derived: sum of 2 quarters · filed 2026-08-11 | $2.17M derived: sum of 3 quarters · filed 2026-08-11 | |
| 2025-06-30 | $766.00K 10-Q · filed 2026-08-11 | $1.52M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $758.00K 10-Q · filed 2026-08-11 | |||
| 2024-12-31 | $4.12M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $1.14M 10-Q · filed 2025-11-10 | $2.37M derived: sum of 2 quarters · filed 2025-11-10 | $3.28M derived: sum of 3 quarters · filed 2025-11-10 | |
| 2024-06-30 | $1.23M 10-Q · filed 2025-11-10 | $2.14M derived: sum of 2 quarters · filed 2025-11-10 | ||
| 2024-03-31 | $910.00K 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $2.74M 10-K · filed 2025-03-06 | |||
| 2023-09-30 | $745.00K 10-Q · filed 2024-11-12 | $1.18M derived: sum of 2 quarters · filed 2024-11-12 | $1.80M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $439.00K 10-Q · filed 2024-11-12 | $1.06M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $617.00K 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $2.46M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $641.00K 10-Q · filed 2023-11-14 | $1.21M derived: sum of 2 quarters · filed 2023-11-14 | $1.82M derived: sum of 3 quarters · filed 2023-11-14 | |
| 2022-06-30 | $571.00K 10-Q · filed 2023-11-14 | $1.18M derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2022-03-31 | $613.00K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $2.21M 10-K · filed 2023-03-07 | |||
| 2021-09-30 | $580.00K 10-Q · filed 2022-11-03 | $1.04M derived: sum of 2 quarters · filed 2022-11-03 | $1.50M derived: sum of 3 quarters · filed 2022-11-03 | $1.86M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $465.00K 10-Q · filed 2022-11-03 | $921.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.28M derived: sum of 3 quarters · filed 2022-11-03 | $1.52M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-03-31 | $456.00K 10-Q · filed 2022-11-03 | $814.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.05M derived: sum of 3 quarters · filed 2022-11-03 | $1.27M derived: sum of 4 quarters · filed 2022-11-03 |
| 2020-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $595.00K derived: sum of 2 quarters · filed 2022-03-08 | $815.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.08M 10-K · filed 2022-03-08 |
| 2020-09-30 | $237.00K 10-Q · filed 2021-11-12 | $457.00K derived: sum of 2 quarters · filed 2021-11-12 | $726.00K 10-Q · filed 2020-10-29 | $985.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $220.00K 10-Q · filed 2021-11-12 | $489.00K 10-Q · filed 2020-08-03 | $748.00K derived: sum of 3 quarters · filed 2021-11-12 | $843.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-03-31 | $269.00K 10-Q · filed 2021-11-12 | $528.00K derived: sum of 2 quarters · filed 2021-11-12 | $623.00K derived: sum of 3 quarters · filed 2021-11-12 | $662.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2019-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $354.00K derived: sum of 2 quarters · filed 2021-02-24 | $393.00K derived: sum of 3 quarters · filed 2021-02-24 | $515.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $95.00K 10-Q · filed 2020-10-29 | $134.00K derived: sum of 2 quarters · filed 2020-10-29 | $256.00K 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $39.00K 10-Q · filed 2020-08-03 | $161.00K 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $122.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $814.00K 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |